HK1056691A1 - Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia - Google Patents

Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia

Info

Publication number: HK1056691A1
Authority: HK; Hong Kong
Prior art keywords: rosuvastatin; treatment; familial hypercholesterolemia; heterozygous familial; heterozygous
Prior art date: 2000-11-22

Application number

HK03109170A

Other languages

English (en)

Inventor

Raza Ali

Hutchinson Howard Gerard

Original Assignee

Strazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-22

Filing date

2003-12-16

Publication date

2004-02-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9903629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1056691(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-12-16 Application filed by Strazeneca Ab filed Critical Strazeneca Ab

2004-02-27 Publication of HK1056691A1 publication Critical patent/HK1056691A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Epidemiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HK03109170A 2000-11-22 2003-12-16 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia HK1056691A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0028429.9A GB0028429D0 (en)	2000-11-22	2000-11-22	Therapy
PCT/GB2001/005041 WO2002041895A1 (en)	2000-11-22	2001-11-16	Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia

Publications (1)

Publication Number	Publication Date
HK1056691A1 true HK1056691A1 (en)	2004-02-27

Family

ID=9903629

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK03109170A HK1056691A1 (en)	2000-11-22	2003-12-16	Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia

Country Status (35)

Country	Link
US (1)	US6858618B2 (uk)
EP (1)	EP1339409B1 (uk)
JP (2)	JP5062940B2 (uk)
KR (1)	KR100815042B1 (uk)
CN (1)	CN1268339C (uk)
AR (1)	AR031766A1 (uk)
AT (1)	ATE394103T1 (uk)
AU (2)	AU2002214165B9 (uk)
BG (1)	BG66009B1 (uk)
BR (1)	BR0115511A (uk)
CA (1)	CA2429263C (uk)
CY (1)	CY1110428T1 (uk)
CZ (1)	CZ301583B6 (uk)
DE (1)	DE60133921D1 (uk)
DK (1)	DK1339409T3 (uk)
EE (1)	EE05507B1 (uk)
ES (1)	ES2305118T3 (uk)
GB (1)	GB0028429D0 (uk)
HK (1)	HK1056691A1 (uk)
HU (1)	HUP0301380A3 (uk)
IL (2)	IL155919A0 (uk)
IS (1)	IS6819A (uk)
MX (1)	MXPA03004336A (uk)
MY (1)	MY134902A (uk)
NO (1)	NO326245B1 (uk)
NZ (1)	NZ525754A (uk)
PL (1)	PL365386A1 (uk)
PT (1)	PT1339409E (uk)
RU (1)	RU2294744C2 (uk)
SI (1)	SI1339409T1 (uk)
SK (1)	SK6212003A3 (uk)
TW (1)	TWI238720B (uk)
UA (1)	UA75614C2 (uk)
WO (1)	WO2002041895A1 (uk)
ZA (1)	ZA200303636B (uk)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0003305D0 (en)	2000-02-15	2000-04-05	Zeneca Ltd	Pyrimidine derivatives
US7407965B2 (en) *	2003-04-25	2008-08-05	Gilead Sciences, Inc.	Phosphonate analogs for treating metabolic diseases
US7452901B2 (en) *	2003-04-25	2008-11-18	Gilead Sciences, Inc.	Anti-cancer phosphonate analogs
PT1628685E (pt)	2003-04-25	2011-03-16	Gilead Sciences Inc	Análogos de fosfonatos antivirais
US7470724B2 (en) *	2003-04-25	2008-12-30	Gilead Sciences, Inc.	Phosphonate compounds having immuno-modulatory activity
US20090247488A1 (en) *	2003-04-25	2009-10-01	Carina Cannizzaro	Anti-inflammatory phosphonate compounds
US20050261237A1 (en) *	2003-04-25	2005-11-24	Boojamra Constantine G	Nucleoside phosphonate analogs
AU2004233897A1 (en) *	2003-04-25	2004-11-11	Gilead Sciences, Inc.	Kinase inhibitor phosphonate conjugates
CA2657076A1 (en) *	2003-08-28	2005-03-17	Teva Pharmaceutical Industries Ltd.	Process for the preparation of rosuvastatin calcium
GB0322552D0 (en)	2003-09-26	2003-10-29	Astrazeneca Uk Ltd	Therapeutic treatment
US7432273B2 (en) *	2003-10-24	2008-10-07	Gilead Sciences, Inc.	Phosphonate analogs of antimetabolites
US7777034B2 (en)	2003-11-24	2010-08-17	Teva Pharmaceutical Industries Ltd.	Crystalline ammonium salts of rosuvastatin
CN1894221B (zh) *	2003-12-02	2012-08-08	特瓦制药工业有限公司	用于表征罗苏伐他汀的参照标准品
US7851624B2 (en) *	2003-12-24	2010-12-14	Teva Pharamaceutical Industries Ltd.	Triol form of rosuvastatin and synthesis of rosuvastatin
US20070179166A1 (en) *	2003-12-24	2007-08-02	Valerie Niddam-Hildesheim	Process for preparation of statins with high syn to anti ratio
WO2005115377A1 (en) *	2004-05-26	2005-12-08	Kgk Synergize Inc	Functional foods comprising flavonoids and tocotrienols and methods thereof
CA2573857A1 (en) *	2004-07-13	2006-02-16	Teva Pharmaceutical Industries Ltd.	A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step
PL216369B1 (pl)	2004-07-27	2014-03-31	Gilead Sciences	Pochodne fosfonianowe, kompozycje farmaceutyczne zawierające te pochodne oraz zastosowanie tych pochodnych do wytwarzania leku do hamowania wirusa HIV
US7612203B2 (en)	2005-02-22	2009-11-03	Teva Pharmaceutical Industries Ltd.	Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
US20070037979A1 (en) *	2005-02-22	2007-02-15	Valerie Niddam-Hildesheim	Preparation of rosuvastatin
US20070167625A1 (en) *	2005-02-22	2007-07-19	Anna Balanov	Preparation of rosuvastatin
US7868169B2 (en) *	2005-08-16	2011-01-11	Teva Pharmaceutical Industries, Ltd.	Crystalline rosuvastatin intermediate
US8383614B2 (en) *	2008-01-31	2013-02-26	The Trustees Of The University Of Pennsylvania	Hypercholestrolemia and tendinous injuries
US9427437B2 (en)	2008-01-31	2016-08-30	The Trustees Of The University Of Pennsylvania	Hypercholesterolemia and tendinous injuries
CA2725052C (en)	2008-05-27	2014-09-16	Changzhou Pharmaceutical Factory Co., Ltd.	Preparation method of rosuvastatin calcium and its intermediates
DK2307435T3 (da)	2008-07-08	2012-09-10	Gilead Sciences Inc	Salte af HIV-inhibitorforbindelser
EP4023641B1 (en)	2012-09-17	2024-05-01	Madrigal Pharmaceuticals, Inc.	Method of synthesizing thyroid hormone analogs and polymorphs thereof
US9132117B2 (en)	2013-06-17	2015-09-15	Kgk Synergize, Inc	Compositions and methods for glycemic control of subjects with impaired fasting glucose
US10600502B2 (en)	2016-12-20	2020-03-24	Astrazeneca Uk Ltd.	Systems and methods for dispensing a statin medication over the counter
ES2892402T3 (es)	2017-08-01	2022-02-04	Gilead Sciences Inc	Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales
CA3141505A1 (en)	2019-05-27	2020-12-03	Immatics US, Inc.	Viral vectors and their use in adoptive cellular therapy
DE102020111571A1 (de)	2020-03-11	2021-09-16	Immatics US, Inc.	Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
US20220008519A1 (en)	2020-07-09	2022-01-13	Costa Rican Social Security Fund / Caja Costarricense de Seguro Social (CCSS)	Treatment of severe acute respiratory syndrome-related coronavirus infection with klotho
US20220056411A1 (en)	2020-08-21	2022-02-24	Immatics US, Inc.	Methods for isolating cd8+ selected t cells
AU2022213405A1 (en) *	2021-02-01	2023-08-03	Madrigal Pharmaceuticals, Inc.	Therapeutic combinations of rosuvastatin and resmetirom for the treatment of liver disorders or lipid disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2648897B2 (ja) *	1991-07-01	1997-09-03	塩野義製薬株式会社	ピリミジン誘導体
US6369103B1 (en) *	1994-01-18	2002-04-09	Bristol-Myers Squibb Company	Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
GB0001621D0 (en) *	2000-01-26	2000-03-15	Astrazeneca Ab	Pharmaceutical compositions
TWI293877B (en) *	2000-09-20	2008-03-01	Rtp Pharma Inc	Spray drying process and compositions of fenofibrate

2000
- 2000-11-22 GB GBGB0028429.9A patent/GB0028429D0/en not_active Ceased
2001
- 2001-11-16 DE DE60133921T patent/DE60133921D1/de not_active Expired - Lifetime
- 2001-11-16 PL PL01365386A patent/PL365386A1/xx not_active Application Discontinuation
- 2001-11-16 MX MXPA03004336A patent/MXPA03004336A/es unknown
- 2001-11-16 AU AU2002214165A patent/AU2002214165B9/en not_active Revoked
- 2001-11-16 SK SK621-2003A patent/SK6212003A3/sk not_active Application Discontinuation
- 2001-11-16 AU AU1416502A patent/AU1416502A/xx active Pending
- 2001-11-16 PT PT01982623T patent/PT1339409E/pt unknown
- 2001-11-16 CZ CZ20031406A patent/CZ301583B6/cs not_active IP Right Cessation
- 2001-11-16 SI SI200130839T patent/SI1339409T1/sl unknown
- 2001-11-16 KR KR1020037006791A patent/KR100815042B1/ko not_active Ceased
- 2001-11-16 CA CA002429263A patent/CA2429263C/en not_active Expired - Fee Related
- 2001-11-16 EE EEP200300239A patent/EE05507B1/xx not_active IP Right Cessation
- 2001-11-16 AT AT01982623T patent/ATE394103T1/de active
- 2001-11-16 IL IL15591901A patent/IL155919A0/xx unknown
- 2001-11-16 UA UA2003054394A patent/UA75614C2/uk unknown
- 2001-11-16 NZ NZ525754A patent/NZ525754A/en not_active IP Right Cessation
- 2001-11-16 US US10/432,402 patent/US6858618B2/en not_active Expired - Lifetime
- 2001-11-16 WO PCT/GB2001/005041 patent/WO2002041895A1/en active IP Right Grant
- 2001-11-16 CN CNB018221599A patent/CN1268339C/zh not_active Expired - Lifetime
- 2001-11-16 DK DK01982623T patent/DK1339409T3/da active
- 2001-11-16 JP JP2002544073A patent/JP5062940B2/ja not_active Expired - Lifetime
- 2001-11-16 RU RU2003114300/15A patent/RU2294744C2/ru not_active IP Right Cessation
- 2001-11-16 BR BR0115511-3A patent/BR0115511A/pt not_active Application Discontinuation
- 2001-11-16 EP EP01982623A patent/EP1339409B1/en not_active Revoked
- 2001-11-16 HU HU0301380A patent/HUP0301380A3/hu not_active Application Discontinuation
- 2001-11-16 ES ES01982623T patent/ES2305118T3/es not_active Expired - Lifetime
- 2001-11-20 MY MYPI20015303A patent/MY134902A/en unknown
- 2001-11-21 TW TW090128858A patent/TWI238720B/zh not_active IP Right Cessation
- 2001-11-22 AR ARP010105452A patent/AR031766A1/es unknown
2003
- 2003-05-12 ZA ZA200303636A patent/ZA200303636B/en unknown
- 2003-05-13 BG BG107811A patent/BG66009B1/bg unknown
- 2003-05-14 IL IL155919A patent/IL155919A/en unknown
- 2003-05-19 IS IS6819A patent/IS6819A/is unknown
- 2003-05-21 NO NO20032292A patent/NO326245B1/no not_active IP Right Cessation
- 2003-12-16 HK HK03109170A patent/HK1056691A1/xx not_active IP Right Cessation
2008
- 2008-07-07 CY CY20081100703T patent/CY1110428T1/el unknown
2009
- 2009-11-09 JP JP2009255813A patent/JP2010031047A/ja active Pending

Also Published As

Publication number	Publication date
TWI238720B (en)	2005-09-01
IL155919A0 (en)	2003-12-23
NO326245B1 (no)	2008-10-27
CA2429263A1 (en)	2002-05-30
US20040072852A1 (en)	2004-04-15
UA75614C2 (uk)	2006-05-15
EE05507B1 (et)	2012-02-15
JP5062940B2 (ja)	2012-10-31
BR0115511A (pt)	2003-12-30
CY1110428T1 (el)	2015-04-29
DK1339409T3 (da)	2008-09-08
AU1416502A (en)	2002-06-03
CA2429263C (en)	2009-03-17
CZ20031406A3 (cs)	2003-09-17
ATE394103T1 (de)	2008-05-15
HUP0301380A2 (hu)	2003-10-28
BG66009B1 (bg)	2010-10-29
RU2294744C2 (ru)	2007-03-10
PT1339409E (pt)	2008-07-07
SI1339409T1 (sl)	2008-08-31
WO2002041895A1 (en)	2002-05-30
CZ301583B6 (cs)	2010-04-21
KR20030048479A (ko)	2003-06-19
IL155919A (en)	2009-09-01
JP2004522714A (ja)	2004-07-29
HUP0301380A3 (en)	2007-03-28
AU2002214165B9 (en)	2013-07-04
IS6819A (is)	2003-05-19
MY134902A (en)	2007-12-31
EP1339409B1 (en)	2008-05-07
CN1268339C (zh)	2006-08-09
NZ525754A (en)	2004-10-29
KR100815042B1 (ko)	2008-03-18
GB0028429D0 (en)	2001-01-10
US6858618B2 (en)	2005-02-22
AR031766A1 (es)	2003-10-01
BG107811A (bg)	2004-03-31
JP2010031047A (ja)	2010-02-12
CN1630520A (zh)	2005-06-22
PL365386A1 (en)	2005-01-10
EP1339409A1 (en)	2003-09-03
ZA200303636B (en)	2004-08-12
NO20032292L (no)	2003-07-17
SK6212003A3 (en)	2003-11-04
AU2002214165B2 (en)	2006-12-14
ES2305118T3 (es)	2008-11-01
EE200300239A (et)	2003-08-15
DE60133921D1 (de)	2008-06-19
NO20032292D0 (no)	2003-05-21
MXPA03004336A (es)	2003-08-19

Publication	Publication Date	Title
AU1416502A (en)	2002-06-03	Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
GB0109537D0 (en)	2001-06-06	Well treatment fluids and methods for the use thereof
SI1757606T1 (sl)	2009-10-31	Ksantinski derivati za uporabo kot zdravila kot tudi postopek za njihovo pripravo
HK1061212A1 (en)	2004-09-10	Pyranoindazoles and their use for the treatment ofglaucoma
AU2002352389A1 (en)	2003-06-30	Piperazine compounds and their phamaceutical use
GB9912411D0 (en)	1999-07-28	Compounds useful in therapy
GB9912413D0 (en)	1999-07-28	Compounds useful in therapy
IL139899A0 (en)	2002-02-10	Uracil compounds and use thereof
ZA200307475B (en)	2005-01-03	Carbamate compounds for use in the treatment of pain.
GB9912410D0 (en)	1999-07-28	Compounds useful in therapy
GB0119025D0 (en)	2001-09-26	Compounds and their therapeutic use
GB9912416D0 (en)	1999-07-28	Compounds useful in therapy
GB9912415D0 (en)	1999-07-28	Compounds useful in therapy
GB2376943B (en)	2005-03-16	Compounds and their therapeutic use
GB0112237D0 (en)	2001-07-11	Compounds and their therapeutic use
GB0130736D0 (en)	2002-02-06	Compounds and their therapeutic use
GB0128512D0 (en)	2002-01-23	Compounds and their therapeutic use
GB0112689D0 (en)	2001-07-18	Dispenser and treatment means
AU2002357468A1 (en)	2003-05-12	Use of 2-acylindoles in the treatment of tumors
GB9909843D0 (en)	1999-06-23	Compounds and their use
AU145797S (en)	2001-11-02	Medical dressing
GB0018886D0 (en)	2000-09-20	Compounds and their therapeutic use
GB0018885D0 (en)	2000-09-20	Compounds and their therapeutic use
AU2002256588A1 (en)	2003-01-21	Catalase-inactivating compounds and the use thereof
GB9910769D0 (en)	1999-07-07	Compounds useful in therapy

Legal Events

Date	Code	Title	Description
2018-06-08	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20171116